Article
A novel pleuromutilin antibacterial compound, its binding mode and selectivity mechanism
13 Dec 2016
Abstract excerpt
The increasing appearance of pathogenic bacteria with antibiotic resistance is a global threat. Consequently, clinically available potent antibiotics that are active against multidrug resistant pathogens are becoming exceedingly scarce. Ribosomes are a main target for antibiotics, and hence are an objective for novel drug development. Lefamulin, a semi-synthetic pleuromutilin compound highly active against...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
